Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Triferic (Ferric Pyrophosphate Citrate) Administered Orally With Shohl's Solution for the Treatment of Iron-Refractory Iron-Deficiency Anemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02905981
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:01.435931+00:00
Published At
2020-09-02T00:00:00+00:00
Record Updated At
2020-09-22
Results Posted At
2020-09-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Iron-Refractory Iron-Deficiency Anemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-22"
protocolSection.identificationModule.nctId
"NCT02905981"
protocolSection.identificationModule.officialTitle
"Triferic (Ferric Pyrophosphate Citrate) Administered Orally With Shohl\u0027s Solution for the Treatment of Iron-Refractory Iron-Deficiency Anemia"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-09-02"

Study condition terms

  • Iron-Refractory Iron-Deficiency Anemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.